openPR Logo
Press release

Turkey Primary Immunodeficiency Market Development, Trends, Segmentation Analysis

11-08-2022 06:36 AM CET | Health & Medicine

Press release from: Transparency Market Research

Turkey Primary Immunodeficiency Market Development, Trends,

Primary Immunodeficiency Market: Introduction

Transparency Market Research has published a new report titled, 'Global Primary Immunodeficiency Market '. According to the report, the global primary immunodeficiency market was valued at US$ 5.7 Bn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2028. The primary immunodeficiency disorders (PIDs) are clinically heterogeneous disorders, the majority of which arise from genetic defects in immunologically relevant genes. Primary immune deficiencies are present in a heterogeneous manner, and a high index of suspicion is required to diagnose primary immune deficiencies. Any patient with a suspected or proven primary immunodeficiency disorder (PID) should be referred to the care of a clinical immunologist. Immune dysregulation phenotypes of PID are commonplace and include multiorgan autoimmunity, malignancy (particularly hematological), and autoinflammatory pathology such as periodic fever syndromes.

Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3137

In terms of type, the global primary immunodeficiency market has been segmented into antibody deficiency, cellular deficiency, and innate immune. Antibody deficiency has been categorized into agammaglobulinaemia, common variable immune deficiency, selective IgA deficiency, IgG subclass deficiency, and others. Cellular deficiency has been classified into Ataxia Telangiectasia, hyper IgM syndromes, Wiskott-Aldrich syndrome, DiGeorge syndrome, and others. Innate immune has been split into complement deficiencies, hyper IgE syndrome, and others. The antibody deficiency segment captured the largest market share in 2019. The segment is expected to expand at the highest CAGR during the forecast period, owing to rise in need and demand for diagnosis by patients.

Read Report Overview- https://www.transparencymarketresearch.com/primary-immunodeficiency-disease-market.html

Based on treatment type, the global primary immunodeficiency market has been divided into immunoglobuline replacement therapy, antibiotic therapy, stem cell and gene therapy, and others (vaccines, nutritional supplements, and others). The immunoglobuline replacement therapy segment captured the largest market share in 2019. The segment is expected to expand at the highest CAGR during the forecast period due to increase in need and demand for diagnosis by patients.

Get Report Methodology @ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=3137

Primary Immunodeficiency Market: Prominent Regions

North America held a major share of the global primary immunodeficiency market in 2019. Highly structured healthcare industry, presence of key players, and growth strategies of these players are the major factors driving the market in the region. Rise in awareness about benefits of procedures and increase in healthcare expenditure also contribute to the growth of the market in North America. Asia Pacific held the second largest share of the global primary immunodeficiency market in 2019. Growth of the primary immunodeficiency market in the region can be attributed to rise in prevalence of chronic diseases and well-developed health care sector in the region. The market in Asia Pacific is expected to grow at a rapid pace during the forecast period. Increase in the number of people with cardiovascular diseases, product approvals, and rise in awareness about cardiovascular diseases which ultimately lead to regular checkup and diagnosis, are factors anticipated to fuel the growth of the primary immunodeficiency market in the region.

Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=3137

Primary Immunodeficiency Market: Key Players

Key players are expanding their footprint to strengthen their position in the global primary immunodeficiency market. Gradual increase in incidence of primary immunodeficiency diseases globally offers lucrative opportunities to key players to increase their share in the primary immunodeficiency market. Hence, manufacturers are engaging in new product development, collaborations, and distribution to gain market share. Leading players operating in the global primary immunodeficiency market include Shire plc, CSL Behring, Kedrion Biopharma Inc, Grifols, S.A., Octapharma, China Biologic Products Holdings, Inc., Biotest AG, Sanquin, and LFB SA.

More Trending Reports by Transparency Market Research:

Blood Screening and Typing Market- https://www.biospace.com/article/blood-screening-and-typing-market-growth-prospects-trends-and-forecast-up-to-2027/

Endoscopic Balloon Dilators Market- https://www.biospace.com/article/endoscopic-balloon-dilators-market-changing-dietary-habits-and-increasing-incidence-of-chronic-diseases-to-drive-the-market/

Tissue Expander Market- https://www.biospace.com/article/tissue-expander-market-competitive-research-and-precise-outlook-2017-to-2025/

Mobile Cardiac Telemetry Systems Market- https://www.biospace.com/article/mobile-cardiac-telemetry-systems-market-segmentation-and-forecast-analysis-up-to-2031/

Health Intelligent Virtual Assistant Market- https://www.biospace.com/article/health-intelligent-virtual-assistant-market-size-application-analysis-regional-outlook-2021-2031/

Contact

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Turkey Primary Immunodeficiency Market Development, Trends, Segmentation Analysis here

News-ID: 2796316 • Views:

More Releases from Transparency Market Research

Global Cultivated Meat Market to Reach USD 1.79 Billion by 2036, Driven by 19% CAGR, Sustainable Protein Demand and Cellular Agriculture Innovations
Global Cultivated Meat Market to Reach USD 1.79 Billion by 2036, Driven by 19% C …
The global cultivated meat market is entering a new phase of commercial development as advances in cellular agriculture, biotechnology, and food manufacturing reshape the alternative protein landscape. Valued at USD 270.0 million in 2025, the market is projected to reach USD 1,787.0 million by 2036, expanding at a CAGR of 19.0% from 2026 to 2036. Cultivated meat is produced by growing animal cells in controlled environments rather than relying on conventional
Global Ball Valves Market to Reach USD 21.1 Billion by 2036, Driven by Industrial Automation and Water Infrastructure Investments
Global Ball Valves Market to Reach USD 21.1 Billion by 2036, Driven by Industria …
The global ball valves market is entering a period of sustained expansion as industries worldwide increase investments in energy infrastructure, water and wastewater systems, process manufacturing, and industrial automation. Valued at USD 12.7 billion in 2025, the market is projected to reach USD 21.1 billion by 2036, expanding at a CAGR of 5.2% from 2026 to 2036. Ball valves are widely used for reliable flow isolation and control across oil and
Atopic Dermatitis Drugs Market to Reach USD 42.6 Billion by 2036, Driven by Rising Disease Prevalence and Growth of Targeted Therapies
Atopic Dermatitis Drugs Market to Reach USD 42.6 Billion by 2036, Driven by Risi …
The global atopic dermatitis drugs market was valued at USD 18.2 billion in 2025 and is projected to reach USD 42.6 billion by 2036, expanding at a CAGR of 8.1% from 2026 to 2036. Market growth is being supported by the rising prevalence of atopic dermatitis, improving disease awareness, advances in targeted therapies, and the increasing adoption of biologics and Janus kinase (JAK) inhibitors for moderate-to-severe disease. Atopic dermatitis, commonly known
Hoist & Winches Market to Reach USD 7.3 Billion by 2036, Driven by Maritime Trade and Construction Growth
Hoist & Winches Market to Reach USD 7.3 Billion by 2036, Driven by Maritime Trad …
The global hoist & winches market is entering a period of steady expansion as industries worldwide increase investment in construction, infrastructure, maritime logistics, manufacturing, mining, and material handling. Valued at approximately USD 4.2 billion in 2025, the market is projected to reach USD 7.3 billion by 2036, registering a CAGR of 5.3% from 2026 to 2036. Rising maritime trade volumes, expanding construction activity, industrial automation, and growing workplace safety requirements

All 5 Releases


More Releases for Primary

Premier Primary Care Medicine Recognized as a Top Primary Care Doctor in Smyrna, …
Premier Primary Care Medicine has been recognized as one of the Top Primary Care Doctors in Smyrna, GA, a distinction that underscores the practice's dedication to delivering high-quality, patient-focused healthcare to the local community. This recognition affirms the practice's strong reputation for clinical expertise, compassionate service, and commitment to improving long-term health outcomes for patients across Smyrna and surrounding areas. SMYRNA, GA - March 3, 2026 - Premier Primary Care [https://www.premierpcmed.com/]
Premier Primary Care Medicine Recognized as Top-Rated Primary Care Physician in …
Premier Primary Care Medicine has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible, high-quality primary care, same-day and next-day appointments, and an approach centered on long-term patient relationships. Marietta, GA - September 16, 2025 - Premier Primary Care Medicine [https://www.premierpcmed.com/] has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible,
Direct Primary Care Market
Direct Primary Care Market Worth 80.4 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Direct Primary Care Market"- By Type (Clinical Services, Telehealth Services, Laboratory Services, Consultative Services), Care Setting (Office-Based DPC Practices, Home-Based DPC Practices, Telehealth-Only DPC Practices, Hybrid DPC Practices), End Users (Individuals, Employers, Small Businesses, Large Corporations, Insurance Companies (offering DPC as
Primary Sclerosing Cholangitis Market
Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to liver damage and, ultimately, liver failure. The disease progresses slowly and often goes unnoticed in its early stages. Although the exact cause of PSC remains unknown, it is commonly associated with other inflammatory bowel diseases, particularly ulcerative colitis. The management of PSC includes symptom control, slowing disease progression, and
Primary Healthcare Conference 2023
3rd World Congress on Primary Healthcare and Medicare Summit Mercure Roma West, Viale degli Eroi di Cefalonia, 301, 00128 Rome, Italy Email primaryhealthcare@pulsusgathering.org On behalf of the Conference Organizing Committee, we would like to invite all of you for the "3rd Word Congress on Primary Healthcare and Medicare", which is going to be held in Rome, Italy on September 21-23, 2023. Primary Healthcare 2023 focuses on the basic theme "To Manifest the Multimorbidity
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk